Evidence reviews on mood, anxiety, and cognitive wellness.
56 claims reviewed
Some evidence suggests art therapy may benefit patients with depression, trauma, and personality disorders, but the evidence base is limited by small studies and methodological weaknesses. A large RCT found no benefit for schizophrenia, highlighting that effects may be condition-specific.
Moderate evidence supports that structured breathing techniques including box breathing reduce physiological and psychological markers of acute stress. The mechanism involves vagal nerve activation and parasympathetic upregulation. However, most studies test slow breathing generally rather than box breathing specifically.
Strong evidence supports bright light therapy (BLT) as an effective treatment for seasonal affective disorder (SAD) and as an adjunctive therapy for non-seasonal depression. Effect sizes are comparable to antidepressant medications, with faster onset and fewer side effects.
Strong evidence from the landmark ACE Study and subsequent meta-analyses demonstrates a graded dose-response relationship between adverse childhood experiences and adult chronic disease, with individuals reporting 4+ ACEs having 2-4 fold increased risk of heart disease, cancer, and early death.
Strong evidence from animal models and human neuroimaging studies demonstrates that chronic stress exposure is associated with hippocampal volume reduction. Elevated cortisol, PTSD, and major depression are consistently linked to 5-15% smaller hippocampal volumes, with some evidence of reversibility through treatment.
Cognitive behavioral therapy (CBT) is well-established as an effective treatment for anxiety disorders, with large effect sizes demonstrated across multiple meta-analyses. It is considered first-line treatment by major clinical guidelines.
Moderate but preliminary evidence suggests cold water exposure acutely elevates mood through norepinephrine release and beta-endorphin activation, though high-quality RCTs are lacking and safety risks limit broad applicability.
Moderate evidence supports cold water face immersion as an acute anxiety reduction technique. The dive reflex reliably activates parasympathetic tone within 30 seconds, reducing heart rate and sympathetic arousal. Clinical utility in panic disorder and acute distress is promising but undertested in large trials.
Limited but emerging evidence suggests cold water swimming may improve mood and reduce depression symptoms. Case reports and mechanistic hypotheses are promising, but high-quality RCTs are lacking. Significant safety concerns exist regarding cold shock response and hypothermia risk.
Weak-to-moderate evidence suggests creatine may augment antidepressant effects, particularly in women. Brain creatine levels are reduced in depression, and supplementation may improve cerebral bioenergetics, but evidence is limited to a few small trials.
Weak evidence exists for 'dopamine detoxes' as commonly promoted. The concept misrepresents dopamine neuroscience—you cannot deplete or reset dopamine through behavioral abstinence. However, reducing overstimulating behaviors may improve attention and self-regulation through mechanisms unrelated to dopamine levels.
Strong evidence supports EMDR as an effective treatment for PTSD, with clinical outcomes comparable to trauma-focused CBT. It is recommended as a first-line treatment by the WHO, APA, and NICE. The eye movement component's unique contribution remains debated, but overall treatment efficacy is well-established.
Strong evidence shows regular exercise is an effective treatment for mild to moderate depression, with effects comparable to antidepressant medication. Exercise appears most effective when performed at moderate-to-vigorous intensity 3-5 times per week.
Exposure therapy is the most well-established treatment for specific phobias, with decades of evidence showing large effect sizes. It is considered the gold standard by all major clinical guidelines, though approximately 20-40% of patients do not achieve full remission.
Emerging evidence suggests that nature exposure, including forest bathing and greenspace access, is associated with modest blood pressure reductions. However, most studies have methodological limitations and the mechanisms remain incompletely understood.
Strong evidence from multiple large cohort studies demonstrates that financial stress is independently associated with worse cardiovascular outcomes, accelerated biological aging, and increased all-cause mortality, though causal direction and mechanisms remain debated.
Moderate evidence suggests float tank sensory deprivation (REST - Restricted Environmental Stimulation Therapy) reduces state anxiety acutely. Effects are large in magnitude but evidence quality is limited by small sample sizes, lack of adequate control conditions, and minimal long-term follow-up.
Moderate evidence from meta-analyses and systematic reviews supports that gardening activities reduce depression, anxiety, and stress while improving well-being, though most studies have methodological limitations and the active ingredients (nature, exercise, social contact, purpose) are unclear.
Moderate evidence supports forest bathing (shinrin-yoku) for reducing physiological and psychological stress markers. Studies consistently show reductions in cortisol, blood pressure, and heart rate after forest exposure compared to urban environments, though study quality varies and mechanisms remain debated.
Moderate evidence suggests gratitude interventions (journaling, letters, exercises) can improve subjective wellbeing and life satisfaction. However, meta-analyses show effect sizes are smaller than popularly claimed, and benefits may be driven partly by expectation effects and publication bias.
Moderate evidence suggests gratitude journaling before bed can modestly improve subjective sleep quality and reduce pre-sleep worry. Effects are consistent but small, primarily mediated by reduced cognitive arousal at bedtime rather than changes in sleep architecture.
Moderate evidence that gratitude interventions (journaling, letters, counting blessings) produce small-to-moderate improvements in subjective well-being and life satisfaction. Effect sizes are modest (d = 0.3-0.5 vs. controls), benefits are stronger for those with lower baseline well-being, and long-term maintenance of effects is uncertain.
Strong evidence confirms that acute grief, particularly following spousal bereavement, significantly increases risk of myocardial infarction and cardiovascular death. Risk peaks in the first 24 hours to 1 week and remains elevated for months, supporting the concept of 'broken heart syndrome.'
Moderate-to-strong evidence supports bidirectional gut-brain communication influencing mental health. Specific microbial profiles correlate with depression and anxiety, and probiotic interventions show small but significant effects on mood, though causality is still being established.
Moderate evidence supports expressive writing (journaling about traumatic or stressful experiences) for reducing stress and improving health outcomes, with meta-analyses showing small but significant effects. Benefits appear stronger for physical health markers than psychological well-being, and effects are limited in chronic illness populations.
Moderate evidence supports expressive writing and structured journaling for modest improvements in anxiety, depression, and psychological well-being. Effects are small-to-moderate and appear stronger for trauma-related distress.
Moderate evidence suggests expressive writing can reduce rumination, though effects are modest and vary by population. Benefits appear strongest when writing focuses on cognitive reappraisal rather than simply venting emotions, with effects on depressive rumination being more consistent than effects on anxious worry.
Ketamine produces rapid antidepressant effects within hours in treatment-resistant depression patients, a breakthrough finding replicated across multiple RCTs. However, effects are short-lived (days to weeks) and concerns about side effects, abuse potential, and long-term safety remain.
Laboratory studies demonstrate that genuine laughter raises pain thresholds, likely through endorphin release. However, the clinical significance is uncertain, and the broader literature on humor and health outcomes contains contradictory findings.
Weak evidence suggests laughter may transiently increase certain immune markers (NK cell activity, salivary IgA) and reduce cortisol, but studies are small, methodologically limited, and no research demonstrates that laughter prevents infections or improves clinical immune outcomes.
Moderate evidence supports lavender aromatherapy reducing subjective anxiety levels in mild-to-moderate anxiety states. Oral lavender oil capsules (Silexan) show stronger evidence than inhaled aromatherapy, though both demonstrate anxiolytic effects superior to placebo.
Multiple longitudinal studies and meta-analyses suggest loneliness is associated with a 26-40% increased risk of dementia. However, the causal direction remains debated, as early cognitive decline may itself cause social withdrawal.
Growing evidence suggests chronic loneliness is associated with altered immune gene expression, increased inflammation, and elevated mortality risk. However, direct causal evidence linking perceived loneliness to specific immune impairment remains limited.
Moderate evidence shows regular meditation practice is associated with measurable structural and functional brain changes, including increased cortical thickness in attention regions and reduced amygdala reactivity. However, many studies have methodological limitations.
Moderate evidence suggests regular meditation reduces blood pressure by approximately 4-5 mmHg systolic and 2-3 mmHg diastolic. The AHA acknowledges meditation as a reasonable adjunct therapy for hypertension, though effects are smaller than medication and exercise. Transcendental Meditation has the most evidence.
Moderate evidence suggests mindfulness meditation can reduce cortisol levels, though effect sizes are generally small to moderate and study quality varies considerably. The relationship appears real but is not as robust as often claimed in popular media.
Moderate evidence from neuroimaging studies suggests long-term meditators show less age-related gray matter decline and preserved cortical thickness. However, most evidence is cross-sectional, and confounding lifestyle factors in meditators complicate causal interpretation.
Strong evidence from multiple meta-analyses supports that Mindfulness-Based Stress Reduction (MBSR) produces moderate effects on stress, anxiety, and depression symptoms. Effect sizes are comparable to established treatments like CBT, though reporting bias in the literature may inflate estimates.
Moderate-to-weak evidence suggests mindfulness meditation may produce small reductions in blood pressure, with meta-analyses showing statistically significant but clinically modest effects. However, study quality is generally low, and an early comprehensive evidence report found insufficient evidence to recommend meditation for hypertension management.
Moderate evidence suggests mindfulness training improves sustained attention and reduces mind wandering in controlled studies. However, questions remain about whether these gains transfer to untrained cognitive tasks or everyday functioning.
Moderate evidence supports mindfulness meditation reducing chronic pain severity and pain-related disability. Meta-analyses show small to moderate improvements in pain intensity and larger improvements in pain acceptance and functional outcomes. Effects are most consistent for low back pain and fibromyalgia.
Strong evidence from Cochrane reviews and large systematic reviews demonstrates that music listening significantly reduces preoperative anxiety, with effects comparable to midazolam in some studies. Effects are consistent across surgical contexts, though some studies show mixed results depending on outcome measures and timing.
Moderate evidence supports music therapy reducing pain perception across multiple clinical settings. Cochrane reviews consistently find small-to-moderate reductions in self-reported pain, anxiety, and analgesic requirements, with effects most robust for procedural and postoperative pain.
Multiple studies and meta-analyses suggest animal-assisted therapy reduces anxiety in hospitalized patients, with moderate effect sizes. However, methodological limitations including small samples, lack of blinding, and inconsistent protocols limit confidence.
Moderate evidence supports that human-animal interaction acutely reduces cortisol and increases oxytocin, though effects are variable across individuals and long-term health benefits of pet ownership are inconsistent.
Moderate evidence from neuroimaging studies suggests that frequent pornography use is associated with structural and functional brain differences, particularly in reward circuitry and prefrontal regions. However, causality remains unestablished and the concept of 'pornography addiction' itself is debated.
Weak evidence. The original 2010 power posing study claiming hormonal changes (increased testosterone, decreased cortisol) failed to replicate in larger, pre-registered studies. A co-author retracted support. Modest self-reported confidence effects may exist but are small and context-dependent.
Moderate evidence supports psilocybin-assisted therapy for treatment-resistant depression, with multiple RCTs demonstrating rapid and sustained antidepressant effects. One or two doses combined with psychological support produce remission in 25-40% of patients who failed conventional antidepressants.
Moderate evidence supports nature exposure for improving mood and reducing negative affect. Meta-analyses show consistent improvements in positive emotions and reductions in anxiety and rumination after even brief nature exposure (20-30 minutes), though effect sizes are modest and mechanisms are not fully understood.
Statistical associations between social media use and anxiety exist, but effect sizes are very small (comparable to eating potatoes). Causation has not been established, and the relationship appears bidirectional.
Moderate but contested evidence shows associations between social media use and depression in teenagers, though effect sizes are small and a landmark dataset analysis found screen time explains less than 0.5% of variation in adolescent well-being.
Moderate evidence supports that social media use, particularly appearance-focused platforms, worsens body image dissatisfaction. Effects are most pronounced for adolescent girls and young women, with experimental and longitudinal studies showing small but consistent negative effects on body satisfaction.
Moderate but low-quality evidence suggests social prescribing improves subjective well-being and reduces loneliness, though rigorous controlled trials are lacking and the heterogeneous nature of interventions makes systematic evaluation difficult.
Strong evidence from the largest network meta-analysis (Cipriani 2018, 522 trials) confirms SSRIs are more effective than placebo for depression. However, the clinical significance of the effect is debated, particularly for mild-to-moderate cases where the drug-placebo difference is small.
Moderate evidence supports nature exposure lowering cortisol levels. Meta-analyses show salivary cortisol reductions of 12-21% following nature experiences of 20+ minutes, though heterogeneity in study designs and comparison conditions limits certainty about the specific active ingredients.
Moderate evidence that yoga reduces anxiety symptoms, with effect sizes comparable to other active interventions like walking or relaxation training. Meta-analyses show significant reductions in anxiety scores, but study quality is often low due to difficulty blinding participants and heterogeneous yoga protocols.